(Q36036374)

English

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Susan E Shoaf

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Patricia Bricmont

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Suresh Mallikaarjun

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

73

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

579-587

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

2 October 2017

Pharmacokinetic interactions with rifampicin : clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

2 October 2017

Pathophysiology of the aquaporin water channels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

2 October 2017

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

2 October 2017

OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

11 July 2018

Hyponatremia and hypernatremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

11 July 2018

Pharmacokinetics, pharmacodynamics, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending single-dose studies in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

Comparison of two doses and dosing regimens of tolvaptan in congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

FDA approves oral vasopressin antagonist.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.04114.X

21 January 2018

Metabolism of cytochrome P4503A substrates in vivo administered by the same route: lack of correlation between alfentanil clearance and erythromycin breath test.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376434

23 September 2018

In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolvaptan (Samsca) for hyponatremia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2011.04114.X

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36036374&oldid=2143919347"